Mitchell C. Posner to Humans
This is a "connection" page, showing publications Mitchell C. Posner has written about Humans.
Connection Strength
1.081
-
Surgical Oncology Heroes and Legends: Murray Brennan, MD as Interviewed by Mitchell Posner, MD. Ann Surg Oncol. 2024 02; 31(2):724-725.
Score: 0.032
-
Great Debates in Surgical Oncology: An Annals of Surgical Oncology Series. Ann Surg Oncol. 2023 10; 30(11):6318.
Score: 0.031
-
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Netw Open. 2020 02 05; 3(2):e1921290.
Score: 0.024
-
For Gastroesophageal Junction Cancers, Does an "Esophageal" or "Gastric" Surgical Approach Offer Better Perioperative and Oncologic Outcomes? Ann Surg Oncol. 2020 Feb; 27(2):511-517.
Score: 0.024
-
Perioperative Gemcitabine?+?Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial. Ann Surg Oncol. 2019 Dec; 26(13):4489-4497.
Score: 0.023
-
An Update on Randomized Clinical Trials in Gastric Cancer. Surg Oncol Clin N Am. 2017 10; 26(4):621-645.
Score: 0.021
-
The Italian Collaborative Group sets a standard for the treatment of locally advanced head and neck cancer. Ann Oncol. 2017 09 01; 28(9):2051-2054.
Score: 0.020
-
Transhiatal Esophagectomy for Esophageal Cancer. J Laparoendosc Adv Surg Tech A. 2016 Oct; 26(10):752-756.
Score: 0.019
-
Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy. Ann Surg Oncol. 2016 06; 23(6):1956-62.
Score: 0.018
-
Attitudes and Perceptions of Surgical Oncology Fellows: The Right Voice at the Almost Right Time. Ann Surg Oncol. 2015 Nov; 22(12):3761-3.
Score: 0.018
-
Research gaps in pancreatic cancer research and comparative effectiveness research methodologies. Cancer Treat Res. 2015; 164:165-94.
Score: 0.017
-
Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2015 Jul; 22(7):2209-17.
Score: 0.017
-
More harm than good? Ann Surg Oncol. 2014 Sep; 21(9):2817-9.
Score: 0.016
-
Controversies and role of HPV16 in recurrent/metastatic squamous cell cancers of the head and neck. Ann Oncol. 2014 Aug; 25(8):1667-8.
Score: 0.016
-
Optimizing management of colorectal hepatic metastases: now and in the future. Eur J Surg Oncol. 2014 Sep; 40(9):1033-5.
Score: 0.016
-
Society of Surgical Oncology Distinguished Service Award: honoring David P. Winchester, M.D. Ann Surg Oncol. 2014 Jan; 21(1):1-4.
Score: 0.016
-
Modern treatment of gastric gastrointestinal stromal tumors. World J Gastroenterol. 2012 Dec 14; 18(46):6720-8.
Score: 0.015
-
"It's not the destination, it's the journey": 2011 Society of Surgical Oncology presidential address. Ann Surg Oncol. 2012 Jul; 19(7):2073-80.
Score: 0.014
-
A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol. 2012 Feb; 19(2):384-91.
Score: 0.013
-
Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer. Br J Cancer. 2011 Jun 07; 104(12):1896-905.
Score: 0.013
-
Electronic synoptic operative reporting for pancreatic resection. J Am Coll Surg. 2011 Mar; 212(3):425-6; author reply 426.
Score: 0.013
-
Extended follow-up after extended lymphadenectomy for gastric cancer: was it worth the wait? Lancet Oncol. 2010 May; 11(5):404-5.
Score: 0.012
-
Neoadjuvant strategies for the treatment of locally advanced esophageal cancer. J Surg Oncol. 2010 Mar 15; 101(4):299-304.
Score: 0.012
-
A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903. Ann Surg Oncol. 2008 Jan; 15(1):158-64.
Score: 0.010
-
Brennan phenotype and its downstream expression. J Am Coll Surg. 2007 Oct; 205(4 Suppl):S17-21.
Score: 0.010
-
D3 or not D3... that is not the question. Lancet Oncol. 2006 Apr; 7(4):279-80.
Score: 0.009
-
Determinants of unresectability and outcome of patients with occult colorectal hepatic metastases. J Surg Oncol. 2005 Oct 01; 92(1):64-9.
Score: 0.009
-
Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Clin Transplant. 2004 Oct; 18(5):502-12.
Score: 0.008
-
Control of gene therapy by MDR1 and EGR1 promoter sequences in transcriptional targeting by chemotherapy (Review). Int J Oncol. 2004 Mar; 24(3):731-6.
Score: 0.008
-
PDGFRß Signaling Cooperates with ß-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis. Clin Cancer Res. 2024 01 17; 30(2):450-461.
Score: 0.008
-
The staging of gastric cancer: nothing novel but perhaps better. Ann Surg Oncol. 2003 Nov; 10(9):1005-6.
Score: 0.008
-
Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era. Surgery. 2003 Oct; 134(4):656-65; discussion 665-6.
Score: 0.008
-
Integrated Clinical-Molecular Classification of Colorectal Liver Metastases: A Biomarker Analysis of the Phase 3 New EPOC Randomized Clinical Trial. JAMA Oncol. 2023 09 01; 9(9):1245-1254.
Score: 0.008
-
The role of surgery in the management of oesophageal cancer. Lancet Oncol. 2003 Aug; 4(8):481-8.
Score: 0.008
-
Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC): safety and efficacy. Am J Transplant. 2003 Mar; 3(3):312-7.
Score: 0.007
-
Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model. Gene Ther. 2003 Feb; 10(3):206-12.
Score: 0.007
-
Isolated pulmonary recurrence after resection of colorectal hepatic metastases--is resection indicated? Cancer J. 2002 Jul-Aug; 8(4):342-7.
Score: 0.007
-
Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma. Ann Surg Oncol. 2002 Jun; 9(5):500-4.
Score: 0.007
-
Hand-assisted laparoscopic surgery for cancer. Cancer J. 2002 Mar-Apr; 8(2):144-53.
Score: 0.007
-
Utility of Perioperative Measurement of Cell-Free DNA and Circulating Tumor DNA in Informing the Prognosis of GI Cancers: A Systematic Review. JCO Precis Oncol. 2022 02; 6:e2100337.
Score: 0.007
-
Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2001 Nov 01; 51(3):599-604.
Score: 0.007
-
Complete 5-year follow-up of a prospective phase II trial of preoperative chemoradiotherapy for esophageal cancer. Surgery. 2001 Oct; 130(4):620-6; discussion 626-8.
Score: 0.007
-
Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma. Arch Surg. 2001 Jul; 136(7):737-42; discussion 743.
Score: 0.007
-
Cytoreductive Surgery for Selected Patients Whose Metastatic Gastric Cancer was Treated with Systemic Chemotherapy. Ann Surg Oncol. 2021 Aug; 28(8):4433-4443.
Score: 0.006
-
Surgical management of benign tumors of the liver. Int J Gastrointest Cancer. 2001; 30(3):141-6.
Score: 0.006
-
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discov. 2021 02; 11(2):308-325.
Score: 0.006
-
Hepatic resection: effective treatment for primary and secondary tumors. Surgery. 2000 Oct; 128(4):686-93.
Score: 0.006
-
4-Hydroxyacetophenone modulates the actomyosin cytoskeleton to reduce metastasis. Proc Natl Acad Sci U S A. 2020 09 08; 117(36):22423-22429.
Score: 0.006
-
Web-Based Medically Necessary, Time-Sensitive (MeNTS) Procedure Scoring Worksheet: In Reply to Ing and Ing. J Am Coll Surg. 2020 09; 231(3):407.
Score: 0.006
-
Virtual Surgical Fellowship Recruitment During COVID-19 and Its Implications for Resident/Fellow Recruitment in the Future. Ann Surg Oncol. 2020 Dec; 27(Suppl 3):911-915.
Score: 0.006
-
Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg. 2000 May; 135(5):530-4; discussion 534-5.
Score: 0.006
-
Is it ethically appropriate to continue surgical clinical trials during the COVID-19 pandemic? Surgery. 2020 07; 168(1):1-3.
Score: 0.006
-
What Is the Appropriate Use of Laparoscopy over Open Procedures in the Current COVID-19 Climate? J Gastrointest Surg. 2020 07; 24(7):1686-1691.
Score: 0.006
-
Medically Necessary, Time-Sensitive Procedures: Scoring System to Ethically and Efficiently Manage Resource Scarcity and Provider Risk During the COVID-19 Pandemic. J Am Coll Surg. 2020 Aug; 231(2):281-288.
Score: 0.006
-
Facilities that service economically advantaged neighborhoods perform surgical metastasectomy more often for patients with colorectal liver metastases. Cancer. 2020 01 15; 126(2):281-292.
Score: 0.006
-
Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance). Ann Surg Oncol. 2019 Dec; 26(13):4213-4221.
Score: 0.006
-
Total Pancreatectomy with Islet Autotransplantation for the Ampullary Cancer. A Case Report. J Gastrointest Cancer. 2019 09; 50(3):543-547.
Score: 0.006
-
Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden. Ann Oncol. 2019 05 01; 30(5):744-756.
Score: 0.006
-
Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer: Follow-up Results of the ACOSOG Z6051 Randomized Controlled Trial. Ann Surg. 2019 04; 269(4):589-595.
Score: 0.006
-
Activated natural killer cell tumor retention and cytokine production in colon tumor using a tissue-isolated model. J Surg Res. 1999 Mar; 82(1):78-87.
Score: 0.006
-
DNA Methylation Controls Metastasis-Suppressive 14q32-Encoded miRNAs. Cancer Res. 2019 02 01; 79(3):650-662.
Score: 0.006
-
Apoptosis in esophageal cancer following induction chemoradiotherapy. J Surg Res. 1998 Sep; 79(1):20-4.
Score: 0.005
-
p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer. 1998 Jul 01; 83(1):7-18.
Score: 0.005
-
Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction. Cancer J Sci Am. 1998 Jul-Aug; 4(4):237-46.
Score: 0.005
-
Interdisciplinary Oncology Education: a National Survey of Trainees and Program Directors in the United States. J Cancer Educ. 2018 06; 33(3):622-626.
Score: 0.005
-
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Nat Commun. 2018 05 04; 9(1):1793.
Score: 0.005
-
Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions. Ann Oncol. 2018 05 01; 29(5):1130-1140.
Score: 0.005
-
JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non-small Cell Lung Cancers. Mol Cancer Ther. 2018 04; 17(4):732-739.
Score: 0.005
-
Steps to Getting Your Manuscript Published in a High-Quality Medical Journal. Ann Surg Oncol. 2018 Apr; 25(4):850-855.
Score: 0.005
-
Role of nutrition support during induction chemoradiation therapy in esophageal cancer. JPEN J Parenter Enteral Nutr. 1998 Jan-Feb; 22(1):18-21.
Score: 0.005
-
Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. J Surg Oncol. 2018 Mar; 117(3):354-362.
Score: 0.005
-
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. Cancer Discov. 2018 01; 8(1):37-48.
Score: 0.005
-
Is esophagectomy following upfront chemoradiotherapy safe and necessary? Arch Surg. 1997 May; 132(5):481-5; discussion 485-6.
Score: 0.005
-
Chronic hepatitis C virus infection in humans: induction of hepatic nitric oxide synthase and proposed mechanisms for carcinogenesis. J Surg Res. 1997 May; 69(2):321-4.
Score: 0.005
-
Extremes of body mass index and postoperative complications after esophagectomy. Dis Esophagus. 2017 May 01; 30(5):1-6.
Score: 0.005
-
In Vivo Delivery and Therapeutic Effects of a MicroRNA on Colorectal Liver Metastases. Mol Ther. 2017 07 05; 25(7):1588-1595.
Score: 0.005
-
Implementing a resident acute care surgery service: Improving resident education and patient care. Surgery. 2017 03; 161(3):876-883.
Score: 0.005
-
Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones. J Vis Exp. 2016 11 30; (117).
Score: 0.005
-
Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers. Sci Rep. 2016 10 24; 6:35854.
Score: 0.005
-
Primary malignant melanoma of the esophagus. Am J Gastroenterol. 1996 May; 91(5):1048-9.
Score: 0.005
-
Consensus Conference on North American Training in Hepatopancreaticobiliary Surgery: A Review of the Conference and Presentation of Consensus Statements. Am J Transplant. 2016 Apr; 16(4):1086-93.
Score: 0.005
-
Consensus Conference on North American Training in Hepatopancreaticobiliary Surgery: A Review of the Conference and Presentation of Consensus Statements. Ann Surg Oncol. 2016 07; 23(7):2153-60.
Score: 0.005
-
Doubling of 30-Day Mortality by 90 Days After Esophagectomy: A Critical Measure of Outcomes for Quality Improvement. Ann Surg. 2016 Feb; 263(2):286-91.
Score: 0.005
-
Management of the pancreatic stump following pancreaticoduodenectomy. Br J Surg. 1995 Dec; 82(12):1590-7.
Score: 0.005
-
Hyperthermic isolated limb perfusion with tumor necrosis factor alone for melanoma. Cancer J Sci Am. 1995 Nov-Dec; 1(4):274-80.
Score: 0.005
-
Development and usability testing of a web-based self-management intervention for oral cancer survivors and their family caregivers. Eur J Cancer Care (Engl). 2016 Sep; 25(5):806-21.
Score: 0.005
-
Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. JAMA. 2015 Oct 06; 314(13):1346-55.
Score: 0.004
-
Imaging of tumor clones with differential liver colonization. Sci Rep. 2015 Jun 22; 5:10946.
Score: 0.004
-
Preservation of beta cell function after pancreatic islet autotransplantation: University of Chicago experience. Am Surg. 2015 Apr; 81(4):421-7.
Score: 0.004
-
14q32-encoded microRNAs mediate an oligometastatic phenotype. Oncotarget. 2015 Feb 28; 6(6):3540-52.
Score: 0.004
-
The quest for population-level cancer recurrence data; current deficiencies and targets for improvement. J Surg Oncol. 2015 May; 111(6):657-62.
Score: 0.004
-
Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer. J Natl Cancer Inst. 2014 Jul; 106(7).
Score: 0.004
-
Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs. Clin Exp Metastasis. 2014 Aug; 31(6):735-48.
Score: 0.004
-
Geriatric assessment improves prediction of surgical outcomes in older adults undergoing pancreaticoduodenectomy: a prospective cohort study. Ann Surg. 2014 May; 259(5):960-5.
Score: 0.004
-
Complete endoscopic mucosal resection is effective and durable treatment for Barrett's-associated neoplasia. Clin Gastroenterol Hepatol. 2014 Dec; 12(12):2002-10.e1-2.
Score: 0.004
-
Smooth pursuit eye movements with imaginary targets defined by extrafoveal cues. Vision Res. 1994 Mar; 34(6):803-20.
Score: 0.004
-
Impact of hepatectomy surgical complexity on outcomes and hospital quality rankings. Ann Surg Oncol. 2014 Jun; 21(6):1773-80.
Score: 0.004
-
Cancer recurrence: an important but missing variable in national cancer registries. Ann Surg Oncol. 2014 May; 21(5):1520-9.
Score: 0.004
-
Indications for breast-preserving surgery and adjuvant therapy in early breast cancer. Int Surg. 1994 Jan-Mar; 79(1):43-7.
Score: 0.004
-
Optimal management of gastric cancer: results from an international RAND/UCLA expert panel. Ann Surg. 2014 Jan; 259(1):102-8.
Score: 0.004
-
Processes of care in the multidisciplinary treatment of gastric cancer: results of a RAND/UCLA expert panel. JAMA Surg. 2014 Jan; 149(1):18-25.
Score: 0.004
-
National assessment of margin status as a quality indicator after pancreatic cancer surgery. Ann Surg Oncol. 2014 Apr; 21(4):1067-74.
Score: 0.004
-
Supportive care considerations during concurrent chemoradiotherapy for pancreatic adenocarcinoma: lessons learned from clinical experience. Am J Clin Oncol. 2013 Dec; 36(6):637-43.
Score: 0.004
-
What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panel. Surgery. 2013 Nov; 154(5):1100-9.
Score: 0.004
-
Implementing an excellence in teaching recognition system: needs analysis and recommendations. J Surg Educ. 2013 Nov-Dec; 70(6):731-8.
Score: 0.004
-
Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study. J Am Coll Surg. 2013 Aug; 217(2):347-57.e1.
Score: 0.004
-
Prospective clinical trial of diagnostic peritoneal lavage to detect positive peritoneal cytology in patients with gastric cancer. J Surg Oncol. 2013 Jun; 107(8):794-8.
Score: 0.004
-
Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design. Ann Surg Oncol. 2013 Aug; 20(8):2787-95.
Score: 0.004
-
Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs. PLoS One. 2012; 7(12):e50141.
Score: 0.004
-
Predictors of unsuccessful laparoscopic resection of gastric submucosal neoplasms. J Gastrointest Surg. 2013 Feb; 17(2):244-55; discussion 255-6.
Score: 0.004
-
Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers. Cancer Res. 2013 Jan 01; 73(1):184-94.
Score: 0.004
-
Peripheral pulmonary nodules: preoperative percutaneous needle localization with CT guidance. Radiology. 1992 Oct; 185(1):274-6.
Score: 0.004
-
A RAND/UCLA appropriateness study of the management of familial gastric cancer. Ann Surg Oncol. 2013 Feb; 20(2):533-41.
Score: 0.004
-
A phase II trial of continuous infusion cisplatin and 5-fluorouracil with oral calcium leucovorin in colorectal carcinoma. Am J Clin Oncol. 1992 Jun; 15(3):239-41.
Score: 0.004
-
EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointest Endosc. 2012 Feb; 75(2):332-8.
Score: 0.003
-
Non-invasive breast carcinoma. Breast Cancer Res Treat. 1992; 21(3):155-64.
Score: 0.003
-
Cavernous hemangioma of the adrenal gland. J Urol. 1992 Jan; 147(1):110-2.
Score: 0.003
-
MicroRNA expression characterizes oligometastasis(es). PLoS One. 2011; 6(12):e28650.
Score: 0.003
-
MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant. 2011 Oct; 11(10):2110-22.
Score: 0.003
-
Response of human prostate cancer cells and tumors to combining PARP inhibition with ionizing radiation. Mol Cancer Ther. 2011 Jul; 10(7):1185-93.
Score: 0.003
-
Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting. J Clin Oncol. 2011 Mar 01; 29(7):934-43.
Score: 0.003
-
A phase I-II trial of continuous-infusion cisplatin, continuous-infusion 5-fluorouracil, and VP-16 in colorectal carcinoma. Am J Clin Oncol. 1990 Oct; 13(5):455-8.
Score: 0.003
-
Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial. Ann Surg Oncol. 2011 Feb; 18(2):337-44.
Score: 0.003
-
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Med Oncol. 2011 Dec; 28 Suppl 1:S152-61.
Score: 0.003
-
Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Ann Oncol. 2011 Feb; 22(2):348-54.
Score: 0.003
-
Distal extrahepatic cholangiocarcinoma presenting as cholangitis. Dig Dis Sci. 2010 Jul; 55(7):1852-5.
Score: 0.003
-
Society of surgical oncology fellowship training: where we have been, where we are now, and where we are going. J Surg Oncol. 2009 Sep 01; 100(3):179-81.
Score: 0.003
-
Continuous, data-rich appraisal of surgical trainees' operative abilities: a novel approach for measuring performance and providing feedback. J Surg Educ. 2009 Sep-Oct; 66(5):255-63.
Score: 0.003
-
Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Am J Gastroenterol. 2009 Nov; 104(11):2684-92.
Score: 0.003
-
Preemptive surgery for premalignant foregut lesions. J Gastrointest Surg. 2009 Oct; 13(10):1874-87.
Score: 0.003
-
Use of a novel, web-based educational platform facilitates intraoperative training in a surgical oncology fellowship program. Ann Surg Oncol. 2009 May; 16(5):1100-7.
Score: 0.003
-
The desmoid tumor. Not a benign disease. Arch Surg. 1989 Feb; 124(2):191-6.
Score: 0.003
-
Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy. Cancer Gene Ther. 2009 Apr; 16(4):373-81.
Score: 0.003
-
Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? Clin Gastroenterol Hepatol. 2008 Feb; 6(2):159-64.
Score: 0.003
-
Resveratrol is an effective inducer of CArG-driven TNF-alpha gene therapy. Cancer Gene Ther. 2008 Mar; 15(3):133-9.
Score: 0.003
-
Diverse TNFalpha-induced death pathways are enhanced by inhibition of NF-kappaB. Int J Oncol. 2007 Dec; 31(6):1519-28.
Score: 0.003
-
Tumor genotype determines susceptibility to oncolytic herpes simplex virus mutants: strategies for clinical application. Future Oncol. 2007 Oct; 3(5):545-56.
Score: 0.003
-
Systemic delivery of (gamma1)34.5-deleted herpes simplex virus-1 selectively targets and treats distant human xenograft tumors that express high MEK activity. Cancer Res. 2007 Sep 01; 67(17):8301-6.
Score: 0.003
-
Successful palliation of hypercalcemia secondary to metastatic parathyroid cancer: an unusual indication for hepatic resection. J Hepatobiliary Pancreat Surg. 2007; 14(4):410-3.
Score: 0.003
-
A review of resistance patterns and phenotypic changes in gastrointestinal stromal tumors following imatinib mesylate therapy. J Gastrointest Surg. 2007 Jun; 11(6):758-66.
Score: 0.003
-
Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers. Oral Oncol. 2007 Mar; 43(3):289-300.
Score: 0.002
-
Operative trials: the opportunity beckons-an update on the American College of Surgeons Oncology Group. Surgery. 2006 Apr; 139(4):455-9.
Score: 0.002
-
Cyclopamine increases the cytotoxic effects of paclitaxel and radiation but not cisplatin and gemcitabine in Hedgehog expressing pancreatic cancer cells. Cancer Chemother Pharmacol. 2006 Dec; 58(6):765-70.
Score: 0.002
-
Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1. J Virol. 2006 Feb; 80(3):1110-20.
Score: 0.002
-
Ionizing radiation: a genetic switch for cancer therapy. Cancer Gene Ther. 2006 Jan 01; 13(1):1-6.
Score: 0.002
-
Chemo-inducible gene therapy. Anticancer Drugs. 2005 Nov; 16(10):1053-8.
Score: 0.002
-
Ionizing radiation activates late herpes simplex virus 1 promoters via the p38 pathway in tumors treated with oncolytic viruses. Cancer Res. 2005 Oct 15; 65(20):9479-84.
Score: 0.002
-
Presence of distal intramural spread after preoperative combined-modality therapy for adenocarcinoma of the rectum: what is now the appropriate distal resection margin? Surgery. 2005 Oct; 138(4):658-63; discussion 663-4.
Score: 0.002
-
Extrahepatic biliary tract injury: operative management plan. J Trauma. 1985 Sep; 25(9):833-7.
Score: 0.002
-
Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Res. 2005 Apr 15; 65(8):3146-54.
Score: 0.002
-
Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity. Mol Cancer Ther. 2004 Sep; 3(9):1167-75.
Score: 0.002
-
Glioblastoma cells block radiation-induced programmed cell death of endothelial cells. FEBS Lett. 2004 May 07; 565(1-3):167-70.
Score: 0.002
-
Expedition Inspiration Fund for Breast Cancer Research Meeting 2003. Breast Cancer Res Treat. 2003 Jul; 80(2):139-44.
Score: 0.002
-
Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med. 2003 Mar 04; 138(5):424-9.
Score: 0.002
-
Dual induction of the Epo-Egr-TNF-alpha- plasmid in hypoxic human colon adenocarcinoma produces tumor growth delay. Am Surg. 2003 Jan; 69(1):24-7.
Score: 0.002
-
Transcriptional control of viral gene therapy by cisplatin. J Clin Invest. 2002 Aug; 110(3):403-10.
Score: 0.002
-
Determination of the optimal modulatory dose of O6-benzylguanine in patients with surgically resectable tumors. Clin Cancer Res. 2002 Aug; 8(8):2519-23.
Score: 0.002
-
Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance. Cancer J. 2002 Jan-Feb; 8(1):47-54.
Score: 0.002
-
Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene. 2001 Sep 27; 20(43):6196-204.
Score: 0.002
-
Is any method of vascular control superior in hepatic resection of metastatic cancers? Longmire clamping, pringle maneuver, and total vascular isolation. Arch Surg. 2001 May; 136(5):569-75.
Score: 0.002
-
Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. J Clin Oncol. 2001 Jan 15; 19(2):289-98.
Score: 0.002
-
NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity. Cancer Res. 2000 Dec 15; 60(24):6958-63.
Score: 0.002
-
The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors. J Virol. 2000 Dec; 74(23):11008-16.
Score: 0.002
-
Should internal mammary nodes be sampled in the sentinel lymph node era? Ann Surg Oncol. 2000 Apr; 7(3):188-92.
Score: 0.002
-
The giant of the giant schwannomas. J Urol. 1999 Sep; 162(3 Pt 1):791-2.
Score: 0.001
-
Intragenic mutation analysis of the human epidermal growth factor receptor (EGFR) gene in malignant human oral keratinocytes. Cancer Res. 1999 Aug 15; 59(16):4142-7.
Score: 0.001
-
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study. Ann Oncol. 1998 Sep; 9(9):1035-7.
Score: 0.001
-
Thoracoscopic techniques for the management of intrathoracic metastases. Results. Surg Endosc. 1998 Jun; 12(6):842-5.
Score: 0.001
-
Efficacy of cisplatin, 5-fluorouracil, and paclitaxel regimen for carcinoma of the esophagus. Semin Oncol. 1997 Dec; 24(6 Suppl 19):S19-89-S19-92.
Score: 0.001
-
Risk factors for squamous cell carcinoma of the oesophagus. Br J Surg. 1996 Sep; 83(9):1174-85.
Score: 0.001
-
Comparative p53 mutational analysis of multiple primary cancers of the upper aerodigestive tract. Surgery. 1996 Jul; 120(1):45-53.
Score: 0.001
-
Cisplatin and chronic oral etoposide as salvage therapy for advanced colorectal carcinoma. Am J Clin Oncol. 1995 Aug; 18(4):300-2.
Score: 0.001
-
A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. J Allergy Clin Immunol. 1995 May; 95(5 Pt 2):1139-46.
Score: 0.001
-
Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies. J Clin Invest. 1995 Feb; 95(2):732-7.
Score: 0.001
-
Needle-localized thoracoscopic resection of indeterminate pulmonary nodules: impact on management of patients with malignant disease. Ann Surg Oncol. 1995 Jan; 2(1):49-55.
Score: 0.001
-
Induction with OKT3 and prostaglandin E1 in liver transplantation. Transplant Sci. 1994 Dec; 4 Suppl 1:S1-8.
Score: 0.001
-
Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1994 Dec 01; 30(5):1043-50.
Score: 0.001
-
A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann Surg. 1994 Oct; 220(4):436-41; discussion 441-4.
Score: 0.001
-
Needle-localized thoracoscopic resections of small indeterminate pulmonary nodules in transplant patients. Clin Transplant. 1994 Aug; 8(4):378-81.
Score: 0.001
-
Peripheral athero-embolism from the aorta complicating transhiatal esophagectomy. Am Surg. 1994 Aug; 60(8):634-7.
Score: 0.001
-
Phase II study of topotecan in metastatic non-small-cell lung cancer. J Clin Oncol. 1994 Feb; 12(2):347-52.
Score: 0.001
-
Gene therapy of cancer: a pilot study of IL-4-gene-modified fibroblasts admixed with autologous tumor to elicit an immune response. Hum Gene Ther. 1994 Jan; 5(1):41-55.
Score: 0.001
-
Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg. 1993 May; 128(5):559-64.
Score: 0.001
-
Efficacy of multimodality therapy in gastric adenocarcinoma. Semin Surg Oncol. 1993 Jan-Feb; 9(1):19-26.
Score: 0.001
-
Combined modality therapy for stage IIIA non-small cell carcinoma of the lung. Eur J Cancer. 1993; 29A(4):511-5.
Score: 0.001
-
Interstitial hypertension in human breast and colorectal tumors. Cancer Res. 1992 Nov 15; 52(22):6371-4.
Score: 0.001
-
New method of limb deformities correction in children. Bull N Y Acad Med. 1992 Nov; 68(4):447-69.
Score: 0.001
-
Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody. J Clin Invest. 1992 Oct; 90(4):1467-78.
Score: 0.001
-
Cooperativity of neutralizing antibodies directed against the V3 and CD4 binding regions of the human immunodeficiency virus gp120 envelope glycoprotein. J Acquir Immune Defic Syndr (1988). 1992; 5(6):591-9.
Score: 0.001
-
Ilizarov technique in treatment of congenital hand anomalies. Two case reports. Clin Orthop Relat Res. 1991 Dec; (273):268-74.
Score: 0.001
-
Comparison of immune repertoires of Chinese and Philippine patients infected with Schistosoma japonicum. Infect Immun. 1991 Dec; 59(12):4698-700.
Score: 0.001
-
Mesenteric infarction secondary to tumor emboli from primary aortic sarcoma. Guidelines for diagnosis and management. Cancer. 1991 Oct 01; 68(7):1622-7.
Score: 0.001
-
Parotid enlargement in children seropositive for human immunodeficiency virus: imaging findings. AJR Am J Roentgenol. 1991 Sep; 157(3):553-6.
Score: 0.001
-
Early events of RNA polymerase II transcription initiation. Life Sci. 1990; 46(10):729-35.
Score: 0.001
-
Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM). Cancer Treat Rep. 1981 Sep-Oct; 65(9-10):787-91.
Score: 0.000